NBT-578

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameNBT-578
Drug Alias NameNBT-578
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLung NeoplasmsStomach Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNewbio Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesNewbio Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsLung NeoplasmsStomach Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A